ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status.

Primitive hematopoietic cells from several species are known to efflux both Hoechst 33342 and Rhodamine-123. We now show that murine hematopoietic stem cells (HSCs) defined by long-term multilineage repopulation assays efflux both dyes variably according to their developmental or activation status. In day 14.5 murine fetal liver, very few HSCs efflux Hoechst 33342 efficiently, and they are thus not detected as "side population" (SP) cells. HSCs in mouse fetal liver also fail to efflux Rhodamine-123. Both of these features are retained by most of the HSCs present until 4 weeks after birth but are reversed by 8 weeks of age or after a new HSC population is regenerated in adult mice that receive transplants with murine fetal liver cells. Activation of adult HSCs in vivo following 5-fluorouracil treatment, or in vitro with cytokines, induces variable losses in Rhodamine-123 and Hoechst 33342 efflux activities, and HSCs from mdr-1a/1b(-/-) mice show a dramatic decrease in Rhodamine-123 efflux ability. Thus, the Rhodamine-123 and Hoechst 33342 efflux properties of murine HSCs fluctuate in the same fashion as a number of other HSC markers, suggesting these are regulated by a common control mechanism that operates independently of that regulating the regenerative function of HSCs.

[1]  C. Eaves,et al.  Different in vivo repopulating activities of purified hematopoietic stem cells before and after being stimulated to divide in vitro with the same kinetics. , 2003, Experimental hematology.

[2]  M. Goodell,et al.  Phenotype and hematopoietic potential of side population cells throughout embryonic development. , 2003, Blood.

[3]  J. Jackson,et al.  Direct identification and enrichment of retinal stem cells/progenitors by Hoechst dye efflux assay. , 2003, Investigative ophthalmology & visual science.

[4]  N. Iscove,et al.  Hematopoietic stem cells engraft in mice with absolute efficiency , 2003, Nature Immunology.

[5]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[6]  G. Sauvageau,et al.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.

[7]  Irving L. Weissman,et al.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.

[8]  M. Ogawa,et al.  Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. , 2003, Experimental hematology.

[9]  M. Ogawa,et al.  CD38 expression by hematopoietic stem cells of newborn and juvenile mice , 2003, Leukemia.

[10]  Cindy L. Miller,et al.  Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose–response surface analysis , 2002, Biotechnology and bioengineering.

[11]  M. Rudnicki,et al.  Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. , 2002, Experimental hematology.

[12]  M. Rudnicki,et al.  The post‐natal heart contains a myocardial stem cell population , 2002, FEBS letters.

[13]  T. Shimazaki,et al.  Flow cytometric analysis of neural stem cells in the developing and adult mouse brain , 2002, Journal of neuroscience research.

[14]  J. Schuetz,et al.  Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  I. Weissman,et al.  Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem Cells , 2002, Science.

[16]  C. Eaves,et al.  Liver and marrow of adult mdr-1a/1b(-/-) mice show normal generation, function, and multi-tissue trafficking of primitive hematopoietic cells. , 2002, Experimental hematology.

[17]  C. Eaves,et al.  Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity , 2002, Oncogene.

[18]  G. Sauvageau,et al.  HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells Ex Vivo , 2002, Cell.

[19]  Cindy L. Miller,et al.  Quantitation of murine and human hematopoietic stem cells by limiting-dilution analysis in competitively repopulated hosts. , 2002, Methods in molecular medicine.

[20]  A. Eaves,et al.  Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype. , 2001, The Journal of clinical investigation.

[21]  H. Nakauchi,et al.  The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.

[22]  Cindy L. Miller,et al.  Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Ito,et al.  Developmental changes of CD34 expression by murine hematopoietic stem cells. , 2000, Experimental hematology.

[24]  R. Mulligan,et al.  Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. , 2000, Blood.

[25]  C. Verfaillie,et al.  Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow. , 2000, Experimental hematology.

[26]  T. de Witte,et al.  Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance. , 1999, Blood.

[27]  R. Mulligan,et al.  Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.

[28]  C. Eaves,et al.  Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. , 1999, Experimental hematology.

[29]  Cindy L. Miller,et al.  Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Johnson,et al.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species , 1997, Nature Medicine.

[31]  J. Dick,et al.  Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. , 1997, Blood.

[32]  I. Weissman,et al.  Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. , 1997, Blood.

[33]  M. Trevisan,et al.  Cycle initiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivo. , 1996, Blood.

[34]  R. Storb,et al.  Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. , 1996, Blood.

[35]  Andrew W. Murray,et al.  Association of Spindle Assembly Checkpoint Component XMAD2 with Unattached Kinetochores , 1996, Science.

[36]  I. Weissman,et al.  The aging of hematopoietic stem cells , 1996, Nature Medicine.

[37]  R. Hoffman,et al.  Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. , 1996, Blood.

[38]  Hiromitsu Nakauchi,et al.  Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell , 1996, Science.

[39]  P. Lansdorp,et al.  A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse. , 1996, Experimental hematology.

[40]  A. S. Conner,et al.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.

[41]  I. Weissman,et al.  The purification and characterization of fetal liver hematopoietic stem cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Brooks,et al.  Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. , 1995, Blood.

[43]  J. Strouboulis,et al.  Development of hematopoietic stem cell activity in the mouse embryo. , 1994, Immunity.

[44]  N. Wolf,et al.  In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. , 1993, Experimental hematology.

[45]  S. Cory,et al.  Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. , 1993, Blood.

[46]  S. Nishikawa,et al.  Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. , 1993, Blood.

[47]  C. Eaves,et al.  Characterization of primitive hematopoietic cells in normal human peripheral blood. , 1992, Blood.

[48]  M. Ratajczak,et al.  The c-kit proto-oncogene in normal and malignant human hematopoiesis. , 1992, International journal of cell cloning.

[49]  C. Eaves,et al.  Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. , 1991, Experimental hematology.

[50]  I. Lemischka,et al.  Cellular and developmental properties of fetal hematopoietic stem cells , 1990, Cell.

[51]  D. Harrison,et al.  Numbers and functions of transplantable primitive immunohematopoietic stem cells. Effects of age. , 1989, Journal of immunology.

[52]  I. Bertoncello,et al.  Multiparameter analysis of transplantable hemopoietic stem cells: I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. , 1985, Experimental hematology.

[53]  J. Unkeless Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors , 1979, The Journal of experimental medicine.